Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion type Assertion NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_head.
- NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion wasGeneratedBy ECO_0000203 NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_provenance.
- NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion wasDerivedFrom befree-2016 NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_provenance.
- NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion SIO_000772 24196187 NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_provenance.
- NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion evidence source_evidence_literature NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_provenance.
- NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_assertion description "[MED12 mutations were detected in 54% of classical uterine leiomyomas (15/28) and in 15% of cases in myometrium adjacent to leiomyomas (2/13); 34% of leiomyoma/leiomyomatosis in pelvic/retroperitoneal sites (10/29); 0% of extrauterine leiomyomas (0/29); 8% of smooth muscle tumor of uncertain malignant potential (1/12); 30% of uterine leiomyosarcomas (6/20); and 4% of extrauterine leiomyosarcomas (1/25).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1125391.RA5bmoP8PNQgzhKXb36FE7KuddV0GdVc1mEXnUoi07T7E130_provenance.